Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 47 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tonogenchoncel-L (Invossa) Gene Therapy for Regeneration of Cartilage in Patients with Degenerative Arthritis or Osteoarthritis of the Knee	Tonogenchoncel-L (Invossa; TG-C)	Regeneration of cartilage	Musculoskeletal System	2017	View \| Download
Upadacitinib for Ankylosing Spondylitis	Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate)	Ankylosing spondylitis	Musculoskeletal System	2020	View \| Download
Vamorolone for treating Duchenne muscular dystrophy	Vamorolone (VBP15)	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2021	View \| Download
Vosoritide for achondroplasia	Vosoritide (BMN 111)	Achondroplasia	Musculoskeletal System	2020	View \| Download
Vosoritide for treating achondroplasia in children	Vosoritide (BMN 111)	Achondroplasia	Musculoskeletal System	2024	View \| Download
Xeomin (Botulinum neurotoxin type A) for lower limb and/or upper limb spasticity	Botulinum toxin A (Dysport; AbobotulinumtoxinA; Xeomin; Incobotulinumtoxin A; ANT-1207; Botox; OnabotulinumtoxinA; RT002; Daxibotulinumtoxin A; Azzalure; RT-001; NT 201; AGN-151607)	Lower limb spasticity , Upper limb spasticity	Musculoskeletal System	2023	View \| Download
Zilucoplan for treating generalised myasthenia gravis	Zilucoplan (RA101495)	Myasthenia gravis (MG)	Musculoskeletal System	2021	View \| Download